Year: 2024
Type: article
Abstract: I would like to reconsider a recent analysis by Prof. Senn on the statistics of the Pfizer-BioNTech vaccine trial, to express some different opinions and to clarify some theoretical points, especially regarding the clinical applications of Bayesian statistics.
Source: Pharmaceutical Statistics
DOI: 10.1002/pst.2440
Author: Mauro Gasparini
Institution: Politecnico di Torino
Language: English
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Open Access status: hybrid
Estimated APC paid: $4,650
Award: G1351680820
OpenAlex ID: W4402422186